U.S. Markets open in 5 hrs, 19 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,226.94 | 203.52 | 2.03% |
| NASDAQ | 2,154.06 | 41.62 | 1.97% |
| S&P 500 | 1,093.08 | 23.78 | 2.22% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 5.56 01:54 PM EST | |
|---|---|---|
| Day High | 5.75 09:34 AM EST |
|
| Range | 0.19 |
| Volume | 148,780 | |
|---|---|---|
| 30-Day Avg Vol | 182,000 |
|
| Difference | -18.25% |
| Market Cap | 211.98 M | |
|---|---|---|
| Mkt Cap Chg | -2.27 M |
| Shares Out | 37.85 M | |
|---|---|---|
| % Shrs Traded | 0.39% | |
| 1yr EPS Est | -0.387 |
| 52-Wk Low | 2.70 | |
|---|---|---|
| 52-Wk High | 7.98 |
|
| Range | 5.28 |
| Prev Close | 5.66 11/6/09 | |
|---|---|---|
| Today's Open | 5.71 | |
| Change | 0.88% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 1.3 M |
| Revenue (LFY) | 89.57 M | |
|---|---|---|
| Earnings (LFY) | -23.56 M | |
| Earnings (MRQ) | -5.28 M | |
| Next Earn Est | -0.102 | |
| Next Earnings | 12/14/2009 |
|
| EPS (TTM) | -0.63 | |
| 1yr EPS Growth | 37.58% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -14.00 | |
| PEG Ratio | — | |
| Return on Equity | -14.14 | |
| Beta | 1.56 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Health Services |
above for more info
For Enzo Biochem, antisense is perfectly sensible. The biotech company's Enzo Therapeutics subsidiary is developing antisense technology, a kind of gene therapy that switches off disease-causing genes, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.102 12/14/09 | — — |
—
—
|
| Last Quarter | -0.078 7/31/09 | -0.14 7/31/09 |
-0.062
Missed
|
| 2 Quarters Ago | -0.152 4/30/09 | -0.11 4/30/09 |
0.042
Beat
|
| Quarterly - 07/31/2009 | Annual - 2009 | |
|---|---|---|
| Total Revenue | 24.53 M | 89.57 M |
| Gross Profit | 9.63 M | 36.51 M |
| Operating Income | -3.87 M | -19.21 M |
| Net Income | -5.28 M | -23.56 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts